PharmaEssentia remains 2024’s biotech valuation champion in Taiwan, and behind its innovation powerhouse is CSO Dr. Lih-Ling Lin!  With 30+ years of experience at Sanofi & Pfizer, she’s now leading global R&D teams across Taiwan and the U.S. to develop groundbreaking therapies.
What makes her leadership game-changing?

• Ex-Sanofi: Led checkpoint immunology research 
• 20+ years at Pfizer: Senior R&D expertise in innovative drug development 
• Mission at PharmaEssentia: Spearhead next-gen therapies with global impact 

Her journey proves that strategic leadership + cutting-edge science = biotech success! 
Read more: http://bit.ly/v116people
Follow #Globalbio for the latest in biotech & pharma innovations! 
#BiotechLeader #PharmaEssentia #CSO #DrugDiscovery #Immunotherapy #BigPharma #GlobalRND #BiotechSuccess #Innovation #Globalbio